Kimberly-Clark to Acquire Kenvue in $48.7 Billion Deal Kimberly-Clark has agreed to acquire Kenvue, the maker of Tylenol, Band-Aid, and Benadryl, in a $48.7 billion cash-and-stock transact…
Transforming Patient Outcomes with Functional Cancer Profiling Functional cancer profiling is a significant step forward in oncology treat…
Nationals' Net Zero Backflip The Nationals' decision to abandon their net zero position will have costly consequences for regional communi…
Iceland Launches Geothermal Competitiveness Initiative The Government of Iceland has established an expert working group to develop policy…
Beyond DNA: NWO Invests in Infrastructure to Study Sugar-Modified Proteins in Cells A better understanding of protein glycosylation offers…
Fertilizer Application Timing is Key for Corn and Soybean Farmers Corn and soybean farmers often apply fertilizer in November, with roughl…
Was Data Mesh Just a Fad? The data mesh architecture promised to eliminate the inefficiencies and errors of the data lake. When tech giant…
Four Teams Maintain Perfect Start in Farnham League Just four teams have a perfect record a month into this year’s Farnham & District Bill…
Harvard Astrophysicist Avi Loeb Suggests Interstellar Object 3I/ATLAS Could Contain Antimatter Harvard astrophysicist Avi Loeb has suggest…
Stockton Strikes Again as Resilient Magpies Climb to Sixth Maidenhead United Women are unbeaten in three matches and have leapt up to sixt…
ACT Brief: Lilly Seeks FDA Priority Review Eli Lilly's orforglipron may become the first oral GLP-1 therapy reviewed under FDA's new natio…